Development Program Lead, Rare Disease

Alnylam

United States

Hybrid

USD 250,000 - 350,000

Full time

14 days+

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

Alnylam Pharmaceuticals seeks a Senior/Executive Director, Development Program Lead to provide strategic and operational leadership for two early-stage rare disease programs in the hepatobiliary space. The role builds integrated development strategies and leads execution through critical milestones, guiding cross-functional teams and investment decisions.

The candidate must bring meaningful rare disease and early development experience, with the ability to navigate ambiguity, engage

Qualifications

  • Advanced degree in medicine, science, pharmacy, or related discipline.

Responsibilities

  • Lead the development and execution of integrated, cross-functional strategies for early-stage rare disease programs.
  • Establish a clear program vision, strategy, and prioritized milestones aligning scientific, clinical, regulatory, operational, and business considerations.
  • Develop fit-for-purpose program plans reflecting each asset's stage, evidence base, investment level, and future potential while ready to accelerate if data supports further development.
  • Lead cross-functional teams in defining proof-of-concept strategies, decision criteria, data requirements, and sensitivities to evaluate therapeutic potential and inform decisions.
  • Integrate scientific evidence, clinical data, regulatory considerations, patient needs, and external landscape into program strategy and decision-making.
  • Translate complex information into clear recommendations, priorities, and executable plans.
  • Anticipate program risks, establish mitigation plans, and escalate issues to support timely decisions.

Education

Advanced degree in medicine, science, pharmacy, or related discipline

Job description

Alnylam Pharmaceuticals seeks a Senior/Executive Director, Development Program Lead to provide strategic and operational leadership for two early-stage rare disease programs in the hepatobiliary space. The role builds integrated development strategies and leads execution through critical milestones, guiding cross-functional teams and investment decisions.

The candidate must bring meaningful rare disease and early development experience, with the ability to navigate ambiguity, engage

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Senior Program Lead - Early-Stage Rare Disease
Senior Program Lead - Early-Stage Rare Disease

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

Hybrid
USD 247,000 - 334,000
Senior Development Program Lead, Rare Disease
Senior Development Program Lead, Rare Disease

Alnylam Pharmaceuticals, Inc. • United States

Hybrid
USD 210,000 - 310,000
Program Lead, Development - Rare Disease
Program Lead, Development - Rare Disease

Alnylam • United States

Hybrid
USD 250,000 - 350,000
Program Lead, Development - Rare Disease
Program Lead, Development - Rare Disease

Alnylam Pharmaceuticals, Inc. • United States

Hybrid
USD 210,000 - 310,000
Program Lead, Development - Rare Disease
Program Lead, Development - Rare Disease

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

Hybrid
USD 247,000 - 334,000
Associate Director, Program Management
Associate Director, Program Management

Alnylam • United States

Hybrid
USD 150,000 - 210,000
Senior Director, Clinical Research: Hematology & RNAi
Senior Director, Clinical Research: Hematology & RNAi

Myana • Philadelphia

Hybrid
USD 255,000 - 345,000
Medical, dental & vision coverage
Life and disability insurance
401(k) with generous match
+2
Director, Patient Advocacy & Engagement — Rare Diseases
Director, Patient Advocacy & Engagement — Rare Diseases

Civic Science Media • Boston (MA)

Hybrid
USD 120,000 - 180,000
Senior Director, Global Clinical Operations (Rare Diseases)
Senior Director, Global Clinical Operations (Rare Diseases)

Hw3 Llc • United States

On-site
USD 250,000 - 350,000
Director, Clinical Research - RNAi Therapeutics Lead
Director, Clinical Research - RNAi Therapeutics Lead

Alnylam Pharmaceuticals, Inc. • Philadelphia

On-site
USD 255,000 - 345,000
Medical, dental & vision
Life and disability insurance
401(k) with company match
+2